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Background: Carbapenemase-producing Enterobacteriaceae (CPE), including KPC-producing Klebsiella pneumoniae
(KPC-Kpn), are an increasing threat to patient safety.
Objectives: To use WGS to investigate the extent and complexity of carbapenemase gene dissemination in a
controlled KPC outbreak.
Materials and methods: Enterobacteriaceae with reduced ertapenem susceptibility recovered from rectal
screening swabs/clinical samples, during a 3 month KPC outbreak (2013–14), were investigated for carbapene-
mase production, antimicrobial susceptibility, variable-number-tandem-repeat profile and WGS [short-read
(Illumina), long-read (MinION)]. Short-read sequences were used for MLST and plasmid/Tn4401 fingerprinting,
and long-read sequence assemblies for plasmid identification. Phylogenetic analysis used IQTree followed by
ClonalFrameML, and outbreak transmission dynamics were inferred using SCOTTI.
Results: Twenty patients harboured KPC-positive isolates (6 infected, 14 colonized), and 23 distinct KPC-producing
Enterobacteriaceae were identified. Four distinct KPC plasmids were characterized but of 20 KPC-Kpn (from six STs),
17 isolates shared a single pKpQIL-D2 KPC plasmid. All isolates had an identical transposon (Tn4401a), except one
KPC-Kpn (ST661) with a single nucleotide variant. A sporadic case of KPC-Kpn (ST491) with Tn4401a-carrying pKpQIL-
D2 plasmid was identified 10 months before the outbreak. This plasmid was later seen in two other species and other
KPC-Kpn (ST14,ST661) including clonal spread of KPC-Kpn (ST661) from a symptomatic case to nine ward contacts.
Conclusions: WGS of outbreak KPC isolates demonstrated blaKPC dissemination via horizontal transposition
(Tn4401a), plasmid spread (pKpQIL-D2) and clonal spread (K. pneumoniae ST661). Despite rapid outbreak con-
trol, considerable dissemination of blaKPC still occurred among K. pneumoniae and other Enterobacteriaceae,
emphasizing its high transmission potential and the need for enhanced control efforts.
Introduction
Carbapenemase-producing Enterobacteriaceae (CPE) are an
increasing threat to patient safety and the function of healthcare
institutions in Europe and worldwide.1 Genes encoding carbapene-
mases may be integrated in the bacterial chromosome but are
most often located on mobile elements, such as plasmids or trans-
posons, which are transferable between bacterial strains, species
VC The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
3025
J Antimicrob Chemother 2017; 72: 3025–3034
doi:10.1093/jac/dkx264 Advance Access publication 7 August 2017
and genera.1,2 Thus, clinical outbreaks are often complex, compris-
ing varying degrees of clonal, plasmid or transposon-mediated
gene spread. Klebsiella pneumoniae carbapenemases (KPC),
encoded by blaKPC alleles, have disseminated globally, primarily
due to the clonal spread of KPC-producing K. pneumoniae (KPC-
Kpn) strains, such as sequence type (ST) 258.1,3,4 However, in the
last decade, dispersal of the transposable Tn4401 element har-
bouring blaKPC
5–7 amongst diverse plasmid structures, bacterial
clones and species has increasingly been observed.2,8
KPC-Kpn have spread rapidly and extensively in some countries.
In Italy, widespread nosocomial dissemination followed the
introduction of KPC in 2008, leading to one-third of invasive
K. pneumoniae isolates being carbapenem resistant in 2014.9 In
the USA, KPC has spread to most states. In both countries, the out-
breaks were predominantly due to transmission of KPC-Kpn ST258,
and other clonal group 258 STs, such as ST512.1,10
KPC was first recognized in the UK in 2003.11 Since then, the inci-
dence of KPC-producing Enterobacteriaceae (KPC-E) has risen,12
with 664 isolates referred to PHE’s Antimicrobial Resistance and
Healthcare Associated Infections (AMRHAI) Reference Unit in
2015.13 Twenty-three blaKPC variants have been described, but
most UK isolates carry either blaKPC-2, blaKPC-3 or occasionally
blaKPC-4.
14 More than 95% of UK KPC-E originate from northwest
England where transmission has principally occurred horizontally
via variants of an epidemic plasmid (pKpQIL).12,14 When seen out-
side northwest England, previous UK blaKPC isolates have been typ-
ically associated withK. pneumoniae clonal group 258.12,14,15
Whole-genome sequencing (WGS) is a highly discriminatory
typing technique used to investigate pathogen transmission in
nosocomial outbreaks. Genetic relatedness amongst strains is
determined by nucleotide-level variation.16–18 However, analy-
sing plasmid structures using short-read sequencing remains
challenging,19 limiting the complete elucidation of blaKPC trans-
mission networks. Recently, data from long-read platforms, par-
ticularly PacBio’s single molecule real-time (SMRT) sequencers,
have enabled plasmid-level analyses, in some instances leading
to an improved understanding of horizontal blaKPC spread.
8,20
Oxford Nanopore Technology’s (ONT) long-read MinION sequen-
cers represent a potentially quicker and more cost-effective
alternative.
In 2013, Leeds Teaching Hospitals NHS Trust (LTH), UK, experi-
enced a short-lived poly-species KPC-E outbreak on a single hos-
pital ward. We investigated the molecular epidemiology of this
temporo-spatially limited outbreak using WGS and detailed hos-
pital admissions data to investigate the likely transmission mech-
anisms. The characterization of blaKPC plasmid structures was
facilitated by MinION sequencing data, marking the first applica-
tion of MinION long-read sequencing technology to tracking blaKPC
plasmid diversity in a clinical outbreak. We also attempted to eluci-
date the infection prevention and control interventions likely to
have brought the outbreak under control.
Materials and methods
Setting
LTH is a large tertiary referral centre (.2000 beds), including a 32-bed
supra-regional liver unit with eight single rooms, and six 4-bed bays.
Patients are regularly referred from outside the region (including northwest
England) for liver transplantation. The LTH liver unit experienced only rare,
sporadic cases of infection/colonization with KPC-E before 2013 (one case
.18 months prior to outbreak), with no previous evidence of patient-to-
patient CPE transmission. Admission CPE screening using rectal swabs was
commenced for all LTH liver unit admissions in 2011 following the introduc-
tion of UK CPE guidance.21
KPC-E outbreak and case definitions
An outbreak was declared in October 2013 following reference laboratory
confirmation of three LTH liver unit patients carrying KPC-Kpn with the same
variable-number-tandem-repeat (VNTR)22,23 profile (6,4,2,0,2,2,2,3,1). The
initial outbreak definition included patients with KPC-Kpn with this VNTR
type, as it was rare in the UK (19/922 national isolates; J. F. Turton AMRHAI
unpublished data, 2012–13). However, this definition was almost immedi-
ately broadened to include all KPC-E once plasmid dispersal was suspected.
Clinical cases were defined as patients with KPC-E isolated from a clin-
ical sample who had signs and symptoms consistent with infection.
Colonized cases were defined as patients who had KPC-E identified on rec-
tal screening without clinical evidence of infection. Details on ward move-
ments, sampling and clinical outcomes were collected retrospectively from
electronic healthcare records and clinical notes.
Infection prevention and control interventions
A multifaceted infection prevention and control strategy was immediately
implemented when the outbreak was detected and continued until the
outbreak was declared over (January 2014). The strategy targeted five
main areas: hand hygiene, cohorting and isolation, screening, environmen-
tal cleaning, and education (Table S1, available as Supplementary data at
JAC Online). Interventions were regularly reviewed in multidisciplinary out-
break team meetings. The outbreak was limited to patients on a single
ward and interventions were targeted to this location.
CPE screening including microbiology methods
At the outbreak onset, enhanced rectal screening was introduced, i.e. for all
patients on admission and discharge from the liver unit (including to/from
other wards), and weekly following admission. Rectal CPE screening swabs
were cultured using ESBL chromogenic agar with a 10lg ertapenem disc
(Oxoid, Basingstoke, UK) since KPC producers are typically resistant to ceph-
alosporins. Species identification (using MALDI-TOF) was performed for all
Enterobacteriaceae from clinical samples and screening swabs with
reduced ertapenem susceptibility (zone diameter,26 mm, by EUCAST disc
testing24); isolates were phenotypically investigated for carbapenem resist-
ance using the Modified Hodge test, Rosco discs (KPC/Metallo-B-Lactamase
Confirm kit, Rosco, Denmark) and by determining ertapenem MICs (Etest,
bioMe´rieux, UK). All potential CPE-producing isolates were sent to the
AMRHAI Reference Unit for PCR investigation for blaOXA-48, blaIMP, blaNDM,
blaVIM and blaKPC.
25–28 Plasmids were typed using a specifically designed
pKpQIL-like plasmid PCR29 targeting six signature sites.
DNA extraction and sequencing
DNA was extracted from a single colony after subculture of frozen KPC-E iso-
lates using a commercial kit (Quickgene, Fujifilm) as per the manufacturer’s in-
structions, with an additional mechanical lysis step following chemical lysis
(FastPrep, MP Biomedicals). WGS used Illumina Hiseq 2500 sequencing tech-
nology, with a sequencing depth of100%per sample. We selected five iso-
lates for MinION sequencing: one random dominant strain KPC-Kpn-ST661
isolate and four with blaKPC plasmid structures that were thought to be distinct
(short-read WGS-based analysis, three patients). Genomic DNA was isolated
using the Qiagen Genomic-tip 100/G kit (Qiagen, Germany) following the
manufacturer’s recommendations. Isolates were prepared for 2D sequencing
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using the SQK-NSK007 sequencing kit with no DNA shearing and modifica-
tions to minimize DNA fragmentation and preserve plasmid structures (see
Supplementary data: Methods).
Sequence processing and analysis
Species identification was performed on short-read Illumina data using
Kraken30 with a reduced database comprising human, bacterial and viral
genomes. Reads were then mapped to species-specific reference se-
quences and base calling was performed as previously described.31
Resistance mechanisms were identified using resistType (https://github.
com/hangphan/resistType), a method combining both assembly/BLASTn
and mapping of sequencing reads to a panel of known reference mechan-
isms, including both chromosomal and acquired mechanisms.
Consensus FASTA sequences from the pipeline were used to reconstruct
phylogenetic trees for each species with IQTree,32 using a GTR!G model
and a maximum parsimony starting tree. The phylogeny was corrected for
recombination using ClonalFrameML with default parameters.33 Short-
read sequences were assembled using SPAdes34 (version 3.6) and the
assemblies used for in silico multilocus sequence-typing (MLST), plasmid
Inc typing and Tn4401 typing by BLASTn. For plasmid typing, all publicly
available complete plasmids were downloaded from NCBI (query term:
plasmids AND Enterobacteriaceae AND complete sequence), deduplicated,
and plasmids carrying blaKPC alleles were extracted. Additional fully closed
plasmid sequences were obtained from a global KPC study.35 These plas-
mid sequences were then used as references to identify similar blaKPC-car-
rying plasmid structures in the outbreak using BLASTn.
MinION sequencing data were processed by poretools36 to extract 2D
reads. Multiple approaches to generate assemblies were applied using both
MinION long-read and Illumina short-read data, namely hybridSPAdes,34
npScarf37 and Canu38 (Supplementary data: Methods). A plasmid was
defined as circularized if it had .100 bp overlapping ends with 100% se-
quence identity for hybridSPAdes/npScarf assemblies, and .1 kbp overlap-
ping ends at.99% sequence identity for Canu assemblies.
We applied SCOTTI,39 a structured coalescent-based tool for recon-
structing transmission within outbreaks, to the dominant outbreak KPC-Kpn
ST661 isolates, combining epidemiological and chromosomal genomic
data. We masked the recombinant regions detected by ClonalFrameML,
and used the resulting genome alignment as input to SCOTTI, together
with the first date where a KPC-E isolate was detected in a patient, and the
start and end date of each patient’s infection risk period (Supplementary
data: Methods). We used a p prior distribution for the mutation rate (mean
2%10–6)31 and a uniform prior distribution between 14 and 16 for the num-
ber of hosts (also allowing possible non-sampled hosts).
All short-read and long-read WGS data are available in the NCBI reposi-
tory under project number PRJNA353334.
Results
Twenty identified patients (6 cases, 14 colonized; Table 1) were
included in the outbreak analysis; 17 were detected in LTH during
the outbreak period, 2 cases were identified after transfer from
LTH to other UK hospitals and 1 patient was identified (by the
AMRHAI Reference Unit) as a potential index case due to it sharing
a KPC-Kpn-associated pKpQIL-D2 variant plasmid29 (December
2012; case 1). The first KPC-E of each species for each patient was
analysed, giving rise to 23 distinct KPC-E isolates (all blaKPC-
positive) including: 20 K. pneumoniae (6 distinct STs; 15 ST661 and
5 STs with a single isolate), 1 Citrobacter freundii, 1 Klebsiella
oxytoca and 1 Enterobacter cloacae. Two patients (cases 6 and 12)
had two distinct KPC-E and one patient (case 2) had two
K. pneumoniae isolates (with differing antimicrobial susceptibility
profiles) analysed.
The median patient age was 56 years (range 32–76), and 12/20
(60%) patients were male. 8/20 (40%) patients were liver trans-
plant recipients. Most (19/20) cases (cases 2–20) spent time on the
LTH liver unit between July 2013 and January 2014 and were pre-
sumed nosocomial acquisitions (Figure 1). blaKPC was detected
.48 h post-admission for 9 cases. For the remaining 10 patients
(excluding the index case), typically with short-lived but regular ad-
missions to the unit, there was a median 25 days (range 10–125,
IQR 16–73) between the most recent admission to the unit and
first blaKPC detection. Six patients experienced clinical infection
associated with a KPC-producing isolate July 2013–January 2014;
three had KPC-E bacteraemia, and one each had urinary tract,
lower respiratory tract or surgical wound infections. The 30 day all-
cause mortality among KPC-affected patients was 3/20 (15%).
The outbreak was deemed successfully controlled due to the
lack of any new KPC-E colonization episodes/cases in LTH over the
subsequent 21 months. The KPC-positive patients were not for-
mally followed up after discharge as many were resident outside
of Leeds. Of the 17 surviving discharged KPC-positive patients, 3/6
opportunistically screened 3 months post-diagnosis remained
KPC-positive and 2/3 screened 6 months post-diagnosis re-
mained positive. One patient remained KPC-positive 511 days
post-diagnosis. One patient had three negative rectal swabs over a
6 month period, suggestive of blaKPC clearance;
21 the remainder
had insufficient local screens to confirm/refute loss of carriage.
WGS demonstrates multiple modes of transmission
Sequence data were available for all (n"23) isolates (Figure 2).
Twenty-two of 23 isolates had an identical transposon (Tn4401a,5
as in pIT-01C03, GenBank accession: HG969995.1), and one had
just one single nucleotide variant (SNV) resulting in transposon
type Tn4401a[986G. T]. This mutation results in a stop codon at
position 261 in the resolvase/phage integrase protein facilitating
site-specific recombination which could affect Tn4401mobility.
Variable phenotypic susceptibilities and antimicrobial resist-
ance genotypes were noted amongst study isolates (Figure 2).
All isolates carried blaKPC-2; no other carbapenem resistance mech-
anisms were demonstrated. Many also carried the ESBL gene
blaSHV-27 (n"15) and the b-lactamase genes blaTEM-1 (n"21) and
DblaOXA-9 (n"21). Other broad or extended-spectrum b-lacta-
mase genes observed included blaOXA-1 (n"8), blaCTX-M-1 (n"2)
blaCTX-M-9 (n"1) and blaCMY-48 (n"1). Some isolates also carried
aminoglycoside resistance genes. The ciprofloxacin-resistant
phenotype in 12 isolates (.0.5 mg/L) was inconsistently explained
by relevant genotypes. High-level ciprofloxacin resistance
(8.0 mg/L) was seen in nine isolates of which seven carried
qnrB1. For the remainder, chromosomal gyrA mutations (S83Y/F)
and uncharacterized changes in efflux pump activity might have
contributed to resistance. Colistin resistance (8 mg/L) was
observed in one isolate (case 17). WGS data of this isolate revealed
the presence of neither mcr-1 nor mcr-2 but N42D amino acid
change was observed in the chromosomal genemgrBwhose alter-
ations (e.g. gene disruption by insertion sequences, missense or
nonsense point mutations, and small deletions) can confer colistin
resistance.40 The N42D mutation has not, however, to our know-
ledge been previously described as causative.
The WGS-based plasmid typing results mostly agreed with PCR-
based typing (19/20 PCR-positive cases). Nineteen isolates yielded
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Figure 1. Patient admissions to LTH liver unit and other LTH wards during the outbreak period. Red vertical marks are the time of first KPC detection
in the patients, black vertical marks denote the starts and ends of the infection risk periods defined for SCOTTI, green vertical marks denote the clos-
est KPC-negative screening time points (where applicable) before or after the first KPC-positive screening result. This figure appears in colour in the on-
line version of JAC and in black and white in the print version of JAC.
Figure 2. Phenotypic sensitivity and antimicrobial resistance gene prediction results of 23 strains from LTH KPC outbreak (MICs: mg/L measured by
agar dilution at AMRHAI). AMC, co-amoxiclav; FOX, cefoxitin; CIP, ciprofloxacin; TZP, piperacillin/tazobactam; MEM, meropenem; IPM, imipenem; ETP,
ertapenem; GEN, gentamicin; CAZ, ceftazidime; TOB, tobramycin; COL, colistin; AMK, amikacin; TEM, temocillin; TGC, tigecycline. This figure appears in
colour in the online version of JAC and in black and white in the print version of JAC.
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assemblies with contigs highly similar to plasmid pKpQIL-D229
(.95% sequence length match/>99% sequence identity). pKpQIL-
D2 is an IncR/IncFII blaKPC-2 plasmid, differing from pKpQIL in the
partitioning and replication regions, without the pKpQIL signature
replicon IncFIB(pQIL), and also harbouring blaTEM-1 and DblaOXA-9.
pKPC18_LTH from case 18 (Kpne-ST321) was identified as pKpQIL-
D2 by PCR but did not meet our predefined WGS-based plasmid
typing thresholds for a match. However, on more detailed review,
this isolate’s assembly included contigs matching 91% of pKpQIL-
D2 at 99% sequence identity, and would be consistent with it being
classified as a pKpQIL-D2-like plasmid affected by large indels (see
long read results below). The remaining three isolates had distinct
plasmid structures with significant matches to the NCBI plasmid
database (threshold: sequence length match .75%; sequence
identity .95%). Most isolates carried plasmid replicon types IncR
(22/23) and IncFIB (22/23).
blaKPC/Tn4401 plasmid characterization from MinION
long-read sequencing
MinION sequencing coverage for the five selected isolates ranged
from 26% to 43% (Table S2), enough to facilitate complete assem-
bly of the blaKPC/Tn4401-carrying plasmids in 4/5 isolates, either by
hybridSPAdes (n"1) or Canu (n"3, Table S3). The closed structure
of the blaKPC/Tn4401-carrying plasmid of the KPC-Kpn ST661 iso-
lates, pKpQIL-LTH (117 kb), was 99% identical to the IncR/IncFII
pKpQIL-D2 (Figure 3). The blaKPC/Tn4401-carrying plasmids
from C. freundii (pKPC12_1_LTH, 99.3 kb) and KPC-Kpn ST250
(pKPC12_2_LTH, 99.3 kb) from case 12 showed nearly identical
plasmid structure (.99% sequence length match and sequence
identity; Figure 3). This was a novel blaKPC-harbouring IncN/IncR
plasmid, most closely related to pKPC-484 (GenBank accession:
CP008798.1, 85.5 kb, Maryland, USA; 56% sequence length match,
99% sequence identity). The distinct structure of this plasmid com-
pared with the dominant outbreak pKpQIL-D2 plasmid (43% se-
quence length match including regions flanking Tn4401, 99%
sequence identity) implicates either independent import of this
plasmid from an unknown source, or a novel local transfer event of
blaKPC/Tn4401 into a new plasmid backbone, likely via recombin-
ation. The presence of these near-identical plasmids in two differ-
ent species suggests cross-species transmission of this novel
plasmid structure within this patient.
The blaKPC/Tn4401 plasmid pKPC18_LTH from case 18 (KPC-Kpn
ST321, Canu assembly, 106 kb) was an IncR/IncFII pKpQIL-D2-like
plasmid (91% sequence length match, 99% sequence identity;
Figure 3). It differed from pKpQIL-D2 by the deletion of the
DblaOXA-9–blaTEM-1 gene cassette and the insertion of an arsenic
detoxification gene cassette into the pKpQIL-D2 plasmid back-
bone. This patient from northwest England was admitted to LTH in
December 2013, and was first found to be colonized with a KPC-
positive isolate in January 2014. Therefore, this patient might have
carried this plasmid prior to admission to LTH or acquired it locally
from an unidentified source with large indel events potentially
driven by selection pressures.
In the remaining case with a distinct plasmid (KPC-Kpn ST1820,
case 16), manual inspection of the hybridSPAdes assembly
Figure 3. Outbreak KPC plasmids and contigs derived from long-read sequencing of isolates and their alignment to the most closely genetically
matched complete plasmid sequences from NCBI. This figure appears in colour in the online version of JAC and in black and white in the print version
of JAC.
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implicated that there was an assembly error, incorrectly merging
the blaKPC/Tn4401 plasmid contig with the chromosomal contig
(Figure S1). After error correction, the revised blaKPC/Tn4401 contig
pKPC16_LTH (187 kb) was 83% similar to pKPN-262 (Figure 3) har-
bouring the pKpQIL-like IncFII replicon and IncFIB(K) as opposed
to IncFIB(pQil) generally found in pKpQIL-like plasmids. The pa-
tient harbouring pKPC16_LTH was admitted for liver transplant in
December 2013 from Manchester and had negative screening re-
sults for blaKPC on admission. This could imply either a horizontal
transfer of the blaKPC/Tn4401 element from pKpQIL-D2 outbreak
plasmid into another plasmid backbone or an independent acqui-
sition from a local unknown source.
Transmission analysis
WGS-based chromosomal sequences and detailed epidemiolo-
gical data were used to estimate probable blaKPC transmission
routes, with the aim of differentiating between ward-based
dispersal and importation from high-risk areas outside, but
associated with, Leeds. A potential index case of KPC-Kpn (ST491)
with the pKpQIL-D2 Tn4401a-carrying plasmid was identified
10 months before the outbreak. This plasmid was later seen in
other KPC-Kpn (ST14, ST661) and two other species, consistent
with unrecognized plasmid dispersal, and subsequently a strain–
plasmid (K. pneumoniae ST661-pKpQIL-LTH, Figure S2) outbreak
nearly a year later. The transmission network and transmission
phylogenetic tree (Figure 4) suggested that a single case (case 8)
was potentially central to dissemination of ST661-pKpQIL-LTH fol-
lowing probable acquisition from case 3. This symptomatic case
was in a shared bay for a prolonged period prior to KPC detection
(Figure 1), potentially transmitting to nine cases (with .0.4 prob-
ability), of which six were within 2–4 SNPs (cases 4–7, 11 and 15).
Patient-to-patient transmission was not demonstrated between
other cases in the outbreak, for which KPC acquisition was more
likely to relate to unidentified sources, such as unscreened pa-
tients, staff or environmental reservoirs. Cases 2 and 17 (7 SNPs
(a)
(b)
(c)
Figure 4. Transmission analysis results inferred by SCOTTI for the dominant outbreak strain KPC-Kpne ST661 using consensus chromosomal se-
quences and epidemiological data. The ‘maximum clade credibility’ of the posterior coalescent tree (scale in years) was inferred by SCOTTI, taking
into account epidemiological data and transmission processes. This figure appears in colour in the online version of JAC and in black and white in the
print version of JAC.
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apart) plausibly represented an indirect transmission link, probably
through multiple transmission chains. Although case 17 was .10
SNPs different from other clonal strains, case 2 was 4–11 SNPs
apart from the remaining cases. Due to large differences in hos-
pital stays and times from colonization to sampling, coalescent
times within hosts vary, giving rise to a broad range of SNP dis-
tances, and therefore absolute SNP distance thresholds are not in-
formative and often bias to discriminate direct transmission links.
Discussion
This is the first report of the detailed molecular epidemiology of a
successfully controlled KPC-E outbreak in the UK. This study also
marks the first application of MinION long-read sequencing to in-
vestigate blaKPC plasmid diversity in a clinical outbreak. This noso-
comial outbreak, involving 23 isolates from just 20 patients,
demonstrated blaKPC dissemination via multiple routes, including
clonal spread of a bacterial strain in conjunction with a pKpQIL-D2
plasmid (K. pneumoniae ST661, 15 cases), horizontal transfer of
the outbreak pKpQIL-D2 plasmid to other STs/species (5 cases)
most likely following its introduction via an index case 10 months
previously, and either horizontal transposition (Tn4401a transmis-
sion from the outbreak pKpQIL-D2 plasmid to other distinct plas-
mids) or external import of blaKPC/Tn4401 plasmids. This small
outbreak included striking genetic diversity (six K. pneumoniae lin-
eages, cross-species plasmid transmission within patients, four
distinct plasmid types) and highlights the relative impact of symp-
tomatic patients, non-K. pneumoniae KPC-E, environmental reser-
voirs and unscreened individuals in blaKPC dissemination (despite
high-density contact-screening). The initial outbreak definition
capturing only KPC-Kpn with the same VNTR type failed to demon-
strate the extent of blaKPC transmission, and reaffirms the need for
consideration of multispecies involvement early in putative out-
breaks. Patient-to-patient KPC-E transmission outside the liver unit
could not be excluded but was thought unlikely as no new cases/
colonized patients were detected outside the liver unit during the
outbreak, or subsequently.
This outbreak demonstrates the difficulty in identifying trans-
mission events between CPE cases, even with the aid of high-
intensity screening, short-read WGS data and long-read plasmid
sequencing. We demonstrated a high colonized : infected patient
ratio (3:1) compared with other outbreaks,41 possibly reflecting
more intensive screening or a lower rate of clinical infection in
colonized individuals. Our analysis demonstrates probable dissem-
ination of ST661-pKpQIL-D2 from a central source to nine cases,
and indirect transmission for the remainder, supporting the exist-
ence of alternative unscreened reservoirs. Long-read MinION
sequencing proved to be beneficial for high-resolution plasmid
tracking, but still suffered from sequencing and bioinformatics limi-
tations, resulting in an erroneous result in one assembly.
Improvements in sequencing protocols to enrich for longer reads,
better bioinformatics tools (assemblers) independent of highly
skilled bioinformatics support, and cost reductions are required to
implement routine WGS-based plasmid tracking. Additionally, al-
though same-day, direct from sample, turnaround time as dem-
onstrated for Mycobacterium tuberculosis diagnosis42 has not
yet been achieved for Enterobacteriaceae species, current devel-
opments in culture-based laboratory protocols allow sample
preparation for long-read sequencing to be completed in 8 h
(6 h DNA extraction; 10 min or 1.5 h options for sequence library
preparation; ONT). Subsequently, 80% of sequencing data can be
obtained within the first 10 h of a 48 h sequencing run,42 and bio-
informatics analysis can be performed in 4–5 h. This allows poten-
tial turnaround times of ,24 h from culture positivity to initial
outbreak analysis.
Nosocomial CPE outbreaks may evolve into regional endemicity
if transmission chains between patients/other reservoirs cannot be
interrupted. Patient transfer from high-prevalence KPC-E centres in
northwest England to the Leeds supra-regional liver unit were fre-
quent during this outbreak, representing multiple opportunities for
reintroductions. A recent study suggests the most probable source
of CPE is from readmission of patients from the same hospital/re-
gion rather than transfer between regions.15 Despite detailed gen-
etic analysis it was difficult to differentiate clearly between
importation of resistance vectors and patient-to-patient KPC-E
transmission in this outbreak. However, the rare plasmid-type, dis-
semination of a rare lineage (ST661) and the fact that the outbreak
was successfully controlled suggests local transmission was the
dominant source of acquisition. Given that all patients on the unit
were screened following detection of the outbreak, undetected
human reservoirs were a less likely source of KPC acquisition than
environmental persistence. Hydrogen peroxide vapour treatment
of the unit on two occasions, along with strict patient cohorting
and screening, may have contributed significantly to halting the
outbreak.
This outbreak resulted in changes to clinical care: transplant as-
sessments were transferred to the outpatient setting and included
CPE screening, and strict algorithms for admission screening/isola-
tion on the liver unit, discharge CPE screening and carbapenem-
sparing antibiotic prescribing strategies were implemented. It was
not possible to evaluate the relative impact of each of these inter-
ventions on reducing CPE transmission.
There were several limitations of this study, mostly relating to
the potential to have underestimated cases/colonization episodes.
Phenotypic tests were used to identify potential CPE producers dur-
ing the outbreak; since then, more sensitive and specific PCR-
based CPE detection has been implemented.43,44 There was a lack
of high-intensity screening of asymptomatic patients prior to out-
break detection (July–October 2013). However, routine CPE admis-
sion screening was in place during this period. Repeat KPC-E
isolates from individual patients were not available. Analysis of the
evolution of KPC-E strains within individuals over time may have
provided further information about the genetic mechanisms asso-
ciated with blaKPC dispersal. Finally, there are few publically avail-
able UK KPC-carrying whole-genome and plasmid sequences,
limiting our ability to contextualize the Leeds strains.
We emphasize that there is considerable potential for rapid dis-
semination of carbapenemase genes among Klebsiella spp. and
between Enterobacteriaceae, despite the implementation of ex-
tensive infection control interventions. Tracking transmission net-
works is challenging, even with detailed epidemiological and WGS
data, due to the mobility and evolution of mobile genetic elem-
ents. Publicly available national CPE sequence data will enable
local institutions to contextualize outbreak strains and identify the
role of importation versus patient-to-patient transmission in re-
sponse to increases in CPE incidence and outbreaks.
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